Prescriptions for Success
-
bookmark
-
print
BMO is proud to host the 5th annual Prescriptions for Success Healthcare Conference, a 100% virtual conference kicking off tomorrow.
This multi-track conference will create a forum for robust conversation on the state of health care across the Biotechnology, Pharmaceutical, and Healthcare Services industries. We will host nearly 60 presenting companies and discuss topics including implications from COVID-19, pipeline development in areas such as rare disease and oncology, as well as health insurance pricing and utilization.
A keynote by Eric Feigl-Ding will address vaccine development and where the public may be misinformed on COVID-19, the prevention and treatment of certain life-threatening diseases, important considerations related to drug safety, the outlook for Medicare and public policy.
Our healthcare services team will host Willis Towers Watson for a discussion of health plan pricing and product trends in the post-pandemic market; our Biopharma team will host a therapeutics panel with two leading dermatologists on emerging treatment modalities for atopic dermatitis and psoriasis.
For more information about the conference.
Thanks to all our clients for taking part in this journey with us.
#BMOConference
#Healthcare
Prescriptions for Success
Senior Advisor to the CEO
Effective November 1, 2023, Dan Barclay will retire as Chief Executive Officer & Group Head, Capital Markets, and transition to a role as Senior Advisor to the …
Effective November 1, 2023, Dan Barclay will retire as Chief Executive Officer & Group Head, Capital Markets, and transition to a role as Senior Advisor to the …
VIEW FULL PROFILE- Minute Read
- Listen Stop
- Text Bigger | Text Smaller
BMO is proud to host the 5th annual Prescriptions for Success Healthcare Conference, a 100% virtual conference kicking off tomorrow.
This multi-track conference will create a forum for robust conversation on the state of health care across the Biotechnology, Pharmaceutical, and Healthcare Services industries. We will host nearly 60 presenting companies and discuss topics including implications from COVID-19, pipeline development in areas such as rare disease and oncology, as well as health insurance pricing and utilization.
A keynote by Eric Feigl-Ding will address vaccine development and where the public may be misinformed on COVID-19, the prevention and treatment of certain life-threatening diseases, important considerations related to drug safety, the outlook for Medicare and public policy.
Our healthcare services team will host Willis Towers Watson for a discussion of health plan pricing and product trends in the post-pandemic market; our Biopharma team will host a therapeutics panel with two leading dermatologists on emerging treatment modalities for atopic dermatitis and psoriasis.
For more information about the conference.
Thanks to all our clients for taking part in this journey with us.
#BMOConference
#Healthcare
You might also be interested in
The Globe and Mail: For Canada and its U.S. trade relationship, complacency equals sleepwalking
Private Equity Finds Comfort Amid Uncertainty in Agribusiness Sector
Inaugural BMO Obesity Summit Focuses on Therapeutics and Combating a Growing Epidemic
Infrastructure is Key to a Competitive Market in North America – US-Canada Summit
Leading Johnson & Johnson to a Vaccine Triumph: A Conversation with Alex Gorsky
Forging Ahead in the Energy Transition: Darryl White to Global Reserve and Asset Managers
BMO Hosts World-Leading Farm to Market Conference for 16th Consecutive Year
BMO Capital Markets to host 2020 Prescriptions for Success Healthcare Virtual Conference